Attenuating mutations of the matrix gene of influenza A/WSN/33 virus

被引:18
|
作者
Liu, T [1 ]
Ye, ZP [1 ]
机构
[1] US FDA, Ctr Biol Evaluat & Res, Off Vaccines Res & Review, Div Viral Prod,Lab Pediat & Resp Viral Dis, Bethesda, MD USA
关键词
D O I
10.1128/JVI.79.3.1918-1923.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The matrix protein (MI) of influenza virus plays an essential role in viral replication. Our previous studies have shown that basic amino acids 101RKLKR105 of M1 are involved in RNP binding and nuclear localization. For the present work, the functions of 101RKLKR105 were studied by introducing mutations into the M gene of influenza virus A/WSN/33 by reverse genetic methods. Individual substitution, R101S or R105S, had a minimal effect on viral replication. In contrast, the double mutation R101S-R105S was synergistic and resulted in temperature sensitivity reflected by reduced viral replication at a restrictive temperature. To investigate the in vivo effect on infection, BALB/c mice were infected with either A/WSN/33 wild-type (Wt) or mutant viruses and assessed for signs of illness, viral replication in the lungs, and survival rates. The results from mouse studies indicated that the R101S-R105S double mutant virus was strongly attenuated, while single mutant viruses R101S and R105S were minimally attenuated compared to AiWSN33 Wt under the same conditions. In challenge studies, mice immunized by infection with R101S-R105S were fully protected from lethal challenge with A/WSN/33. The replication and attenuating properties of R101S-R105S suggest its potential in development of live influenza virus vaccines.
引用
收藏
页码:1918 / 1923
页数:6
相关论文
共 50 条
  • [41] Attenuating mutations in the West Nile virus NS3 protein
    Ebel, Gregory D.
    Shi, Pei-Yong
    Kramer, Laura D.
    Jerzak, Greta V.
    Bennett, Corey J.
    Bernard, Kristen A.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (05): : 189 - 189
  • [42] COMPLETE NUCLEOTIDE-SEQUENCE OF THE NONSTRUCTURAL GENE OF THE HUMAN INFLUENZA-VIRUS STRAIN A/WS/33
    WARD, AC
    AZAD, AA
    MACREADIE, IG
    MCKIMMBRESCHKIN, JL
    NUCLEIC ACIDS RESEARCH, 1993, 21 (09) : 2257 - 2257
  • [43] ANALYSIS OF THE SIGNALS FOR POLARIZED TRANSPORT OF INFLUENZA-VIRUS (A/WSN/33) NEURAMINIDASE AND HUMAN TRANSFERRIN RECEPTOR, TYPE-II TRANSMEMBRANE PROTEINS
    KUNDU, A
    NAYAK, DP
    JOURNAL OF VIROLOGY, 1994, 68 (03) : 1812 - 1818
  • [44] Association of influenza virus matrix protein with ribonucleoproteins
    Ye, ZP
    Liu, T
    Offringa, DP
    McInnis, J
    Levandowski, RA
    JOURNAL OF VIROLOGY, 1999, 73 (09) : 7467 - 7473
  • [45] SELECTIVE-INHIBITION OF WSN INFLUENZA-VIRUS HEMOLYSIS BY PEA LECTIN
    KRAH, DL
    CHOPPIN, PW
    JOURNAL OF GENERAL VIROLOGY, 1988, 69 : 717 - 722
  • [46] Accessory Gene Products of Influenza A Virus
    Pinto, Rute M.
    Lycett, Samantha
    Gaunt, Eleanor
    Digard, Paul
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2021, 11 (12):
  • [47] The Plowright vaccine strain of Rinderpest virus has attenuating mutations in most genes
    Baron, MD
    Banyard, AC
    Parida, S
    Barrett, T
    JOURNAL OF GENERAL VIROLOGY, 2005, 86 : 1093 - 1101
  • [48] Mutations in Influenza A Virus and Clinical Implications in Transplant Recipients
    Ferreira, V.
    Humar, A.
    Cordero, E.
    Blumberg, E.
    Husain, S.
    Kalpoe, J.
    Kumar, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 287 - 287
  • [49] Optimal Control of Influenza Epidemic Model with Virus Mutations
    Elena, Gubar
    Zhu, Quanyan
    2013 EUROPEAN CONTROL CONFERENCE (ECC), 2013, : 3131 - 3136
  • [50] MAPPING MUTATIONS IN INFLUENZA-A VIRUS RESISTANT TO NORAKIN
    PROSCH, S
    HEIDER, H
    SCHROEDER, C
    SHILOV, AA
    SINITZYN, BV
    BLINOV, VM
    KRUGER, DH
    FROMMEL, C
    FEBS LETTERS, 1990, 267 (01): : 19 - 21